Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
WINDACRE PARTNERSHIP LLC VSXY Victoria's Secret & Co. 13G/A 7.22% 2y
ARMISTICE CAPITAL, LLC AREB American Rebel Holdings Inc 13G 7.42% 2y
ALLIANCEBERNSTEIN L.P. REVG REV Group, Inc. 13G/A 3.4% 2y
FIR TREE CAPITAL MANAGEMENT LP AIRJ AirJoule Technologies Corp. 13G 9.61% 2y
Dragoneer Investment Group, LLC NCNO nCino, Inc. 13G/A 4.1% 2y
Millennium Management LLC PLMJF Plum Acquisition Corp. III 13G/A 8.5% 2y
Thomas Caleca KSCP Knightscope, Inc. 13G/A 1.46% 2y
GREAT POINT PARTNERS LLC ALPN Alpine Immune Sciences, Inc. Common Stock 13G/A 6.37% 2y
Mary Sue Robinson Morrill SCHL Scholastic Corp 13G 9.4% 2y
T. Rowe Price Investment Management, Inc. ICVX Icosavax, Inc. Common Stock 13G 7.8% 2y
JAT Capital Mgmt LP NXH Neighborhood Intelligence, Inc. 13G/A 9.2% 2y
First Trust Capital Management L.P. APCA AP Acquisition Corp 13G 9.88% 2y
HGC Investment Management Inc. KDK Kodiak AI, Inc. 13G 9.76% 2y
SYLEBRA CAPITAL LLC CHGG Chegg, Inc 13G 8.13% 2y
LUCERNE CAPITAL MANAGEMENT LP ADSE Ads-Tec Energy Public Ltd Co 13G/A 10.3% 2y
METEORA CAPITAL, LLC PPHP PHP Ventures Acquisition Corp. Class A Common Stock 13G 6.3% 2y
Jericho Capital Asset Management L.P. MSGE Madison Square Garden Entertainment Corp. 13G 5.6% 2y
Commodore Capital LP ELVN Enliven Therapeutics, Inc. 13G/A 7% 2y
Crestview Partners II GP, L.P. VCTR Victory Capital Holdings, Inc. 13G/A 17.6% 2y
METEORA CAPITAL, LLC RCAC Revelstone Capital Acquisition Corp. Class A Common Stock 13G 8.09% 2y
D. E. Shaw & Co., L.P. BRLS Borealis Foods Inc. 13G/A 0% 2y
Fairmount Funds Management LLC ATXS Astria Therapeutics, Inc. Common Stock 13G/A 9.9% 2y
Venrock Healthcare Capital Partners III, L.P. AMAM Ambrx Biopharma, Inc. Common Stock 13G/A 3.3% 2y
Almitas Capital LLC DMA Destra Multi-Alternative Fund 13G 5.04% 2y
AQR CAPITAL MANAGEMENT LLC CPTAF Captivision Inc. 13G/A 2.08% 2y
AdvisorShares Trust CMND Clearmind Medicine Inc. 13G 5.48% 2y
Shay Capital LLC TBCH Turtle Beach Corp 13G/A 4.96% 2y
AWM Investment Company, Inc. VEEE Twin Vee PowerCats, Co. 13G/A 9.9% 2y
First Trust Capital Management L.P. PHYT Pyrophyte Acquisition Corp. 13G 5.85% 2y
Redmile Group, LLC NRIX Nurix Therapeutics, Inc. 13G/A 9.9% 2y
First Trust Capital Management L.P. FLD Fold Holdings, Inc. 13G 7.53% 2y
COHEN & STEERS, INC. KIM Kimco Realty Corp 13G/A 7.26% 2y
Radcliffe Capital Management, L.P. TGVC TG Venture Acquisition Corp. Class A Common Stock 13G/A 0% 2y
HSG Holding Ltd THCH TH International Ltd 13G/A 9.2% 2y
Hood River Capital Management LLC APLD Applied Digital Corp. 13G 8.08% 2y
Aaron Rollins AIRS Airsculpt Technologies, Inc. 13G/A 24.99% 2y
ALLIANCEBERNSTEIN L.P. BCOW 1895 Bancorp of Wisconsin, Inc. 13G/A 10% 2y
Fourthstone LLC CVLY Codorus Valley Bancorp Inc 13G/A 6.99% 2y
ARMISTICE CAPITAL, LLC SUPN Supernus Pharmaceuticals, Inc. 13G/A 8.51% 2y
DISCOVERY CAPITAL MANAGEMENT, LLC / CT TCRT Alaunos Therapeutics, Inc. 13G/A 1.66% 2y
BIOTECHNOLOGY VALUE FUND L P JANX Janux Therapeutics, Inc. 13G/A 9.9% 2y
Caledonia (Private) Investments Pty Ltd GENI Genius Sports Ltd 13G/A 9.82% 2y
HHLR ADVISORS, LTD. EM Smart Share Global Ltd 13G/A 14% 2y
T. Rowe Price Investment Management, Inc. OEC Orion S.A. 13G 5% 2y
AVENIR CORP CTSO Cytosorbents Corp 13G 6.87% 2y
D. E. Shaw & Co., L.P. AAP Advance Auto Parts Inc 13G/A 5.9% 2y
ALLIANCEBERNSTEIN L.P. FBP First Bancorp 13G/A 5% 2y
PRICE T ROWE ASSOCIATES INC /MD/ FITB Fifth Third Bancorp 13G/A 6.2% 2y
RTW INVESTMENTS, LP BWAY Brainsway Ltd. 13G/A 0% 2y
T. Rowe Price Investment Management, Inc. AIZ Assurant, Inc. 13G/A 9.7% 2y